Table 4.
Adverse reactions and events
Expected | Serious | Total sample | Arm 1 | Arm 2 | |||
---|---|---|---|---|---|---|---|
Study completed | Drop-out | Study completed | Drop-out | ||||
Adverse reactions | |||||||
Allergic reaction, rash | Yes | No | 3 | 0 | 1 | 1 | 1 |
Headache | Yes | No | 3 | 1 | 1 | 0 | 1 |
Tachycardia, bradycardia | Yes | No | 2 | 1 | 0 | 1 | 0 |
Hypotension, vasodilation, syncope, edema | Yes | No | 2 | 0 | 0 | 0 | 2 |
Nausea, constipation, diarrhea, flatulence | Yes | No | 3 | 0 | 0 | 1 | 2 |
Hypertension, agitation | No | No | 1 | 0 | 1 | 0 | 0 |
Total adverse reactions | 14 | 2 | 3 | 3 | 6 | ||
Trial drug decreased due to adverse reaction | 1 | 0 | 0 | 1 | 0 | ||
Withdrawn due to adverse reaction | 4 | 0 | 1 | 0 | 3 | ||
Adverse events | |||||||
Cerebral hemorrhage | No | Yes | 1 | 0 | 1 | 0 | 0 |
Incidental carcinoma diagnosis | No | Yes | 3 | 0 | 0 | 3 | 0 |
Varicella zoster virus infection relapse | No | No | 1 | 1 | 0 | 0 | 0 |
Total adverse events | 5 | 1 | 1 | 3 | 0 | ||
Trial drug decreased due to adverse event | 0 | 0 | 0 | 0 | 0 | ||
Withdrawn due to adverse event | 1 | 0 | 1 | 0 | 0 |